News about Global Pharma

Amcor to Showcase Sustainable and Patient-Centric Packaging Innovations at CPHI Frankfurt 2025

At CPHI Frankfurt 2025, Amcor will highlight its extensive portfolio of rigid and flexible packaging solutions, including ClariPPil jars and OSD bottles for oral solid dose applications, alongside its AmSky and high-shield pharma laminates.

Global Pharma | 03/10/2025 | By Dineshwori |  484

FDA Approves Novartis's Rhapsido as First Oral BTK Inhibitor for Chronic Spontaneous Urticaria

The US Food and Drug Administration (FDA) has approved Novartis’ Rhapsido (remibrutinib) as an oral treatment for adult patients with chronic spontaneous urticaria (CSU) who continue to experience symptoms despite H1 antihistamine therapy.

Global Pharma | 03/10/2025 | By Dineshwori |  434

Novavax, Sanofi Deepen Partnership to Include Matrix-M in Pandemic Influenza Vaccine Programme

The expanded partnership allows Sanofi to use Novavax’s Matrix-M adjuvant in its pandemic influenza vaccine candidate programme.

Global Pharma | 01/10/2025 | By Dineshwori |  312

Artemis Acquires Millrock Technology

Under Artemis' ownership, Millrock will continue to operate as an independent company from its facility in Kingston, New York, serving a global customer base.

Global Pharma | 01/10/2025 | By Dineshwori |  275

AbbVie Expands US Biologics and API Manufacturing Capacity, Seeks FDA Approval for Rare Blood Cancer Therapy

AbbVie has begun a USD 70 million expansion of its AbbVie Bioresearch Center (ABC) in Worcester, Massachusetts, and broken ground on a new North Chicago Active Pharmaceutical Ingredient (API) manufacturing facility.

Global Pharma | 01/10/2025 | By Dineshwori |  290

Pfizer signs Agreement with US Government to Lower Drug Costs for American Patients

Pfizer has voluntarily agreed to implement measures designed to ensure Americans receive comparable drug prices to those available in other developed countries and pricing newly launched medicines at parity with other key developed markets.

Global Pharma | 01/10/2025 | By Dineshwori |  237

Biocon Biologics, Amgen Settle Patent Dispute, Paving Way for US Launch of Denosumab Biosimilars

The agreement with Amgen enables Biocon Biologics to launch denosumab biosimilars Bosaya and Aukelso in the US from October 1, 2025.

Global Pharma | 01/10/2025 | By Dineshwori |  403

Lupin Receives Approval from US FDA for Rivaroxaban for Oral Suspension

Lupin’s Rivaroxaban will be manufactured at the company’s Chhatrapati Sambhajinagar facility.

Global Pharma | 01/10/2025 | By Dineshwori |  328

Nyxoah Expands Its Presence in Middle East

Nyxoah expands in the Middle East (ME) with new centres in Dubai, Kuwait and Abu Dhabi after the first Genio implant.

Global Pharma | 30/09/2025 | By Dineshwori |  166

Kai Beckmann to Lead Merck as CEO and Executive Board Chair

The Board of Partners of E. Merck KG appointed Kai Beckmann as future Chairman of the Executive Board and CEO of Merck. Belén Garijo’s tenure to be completed as planned by end of April 2026.

Global Pharma | 30/09/2025 | By Dineshwori |  271